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Ranchers and stockmen are continually faced with the problem of 
maximizing efficiency in their operations. One area that offers great 
promise ·as a means of accomplishing this is that .of increasing the re-
productive efficiency of the beef cow. Improved feeding, breeding, and 
management techniques have made a definite contribution to increasing 
the number of live calves at birth and weaning. However, even with all 
the advances made in the livestock industry in the recent years, the pro-
ducer can still only expect, at best, little more than a 90% calf crop. 
For this reason, much research effort has been devoted in recent years to 
trying to increase calf numbers per ·cow unit through the use of exogenous 
gonadotrophins to induce multiple births. 
One of the primary hormones that has been used in such studies is 
pregnant mare serum gonadotrophin. Many of these ·experiments have been 
quite successful in inducing superovulation and superfetation, in many 
cases too successful in that the cows give birth to too many calves or 
ovulate so many eggs that they do not become pregnant, or the resulting 
pregnancy cannot be maintained. While it is true that other problems 
have also been implicated in the multiple birth studies, such as retained 
placentas, lowered birth weights, reduced fertility and freemartinism in 
the heifer calves, uncontrolled superovulation still ranks as one of the 
most import.ant. If these problems could be solved, the induction of 
1 
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multiple births would not only prove beneficial to the commercial beef 
operator but might also be a great boon to the purebred producer in that 
he could conceivably progeny test his females. 
In addition, knowledge of the endocrine .changes occurring during the 
reproductive cycle is essential if maximum progress in reproductive 
efficiency is to be made. In this regard, little data are available 
conc-erning hormonal fluctuations after PMSG treatment. This study was, 
therefore, primarily concerned with investigating the endocrine response 
of bovine female when PMSG is administered either during the late luteal 
phase or both during the early luteal and late luteal phases of the 
estrous cycle. Such information might yield clu.es to the relationships 
between plasma hormone concentrations after PMSG and subsequent ovulation 
rates and fertility. These data might then demonstrate which endocrine 





The induction of multiple births in beef cattle has been the subject 
of a number of research studies since Casida et al. (1943) reported that 
exogenous gonadotrophic hormones could be used to induce superovulation 
in the bovine. Cole and Hart (1930) first described gonadotrophic acti-
vity in the serum of pregnant mares, and pregnant mares' serum gonadotro-
phin (PMSG) has since become the most commonly used hormone for inducing 
superovulation and superfetation in beef cattle. Many reviews (Hafez 
et al., 1965; Bellows and Short, 1972; Laster, 1971; Johnson, 1972) are 
available concerning the topic of multiple births in the bovine. 
Most investigators have employed a single injection of gonadotrophin 
given in the late luteal phase (day 16-18) of the cycle. However, 
Schilling and Holm (1963) suggested that a series of two injections gave 
better control of the superovulatory response. They reasoned that 1500 
I. U. PMSG given on day five of the estrous cycle might prevent atresia 
of all but one of the early developing follicles and the second injection 
given later in the cycle would cause these follicles to mature rather 
than resulting in uncontrolled follicular growth. Using this treatment 
schedule, these investigators reported that 70% of the treated cows had 
the desired two or three ovulations. 
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This report by Schilling and Holm (1963) stimulated a series of 
investigations at the Fort Reno Research Station to determine the effec-
tiveness of two PMSG injections in inducing multiple births in beef cows. 
Turman et al. ( 1971) reported 23 multiple births from 52 cows conceiving 
at the .first estrus following the second PMSG injection. Similarly, 
Laster et al. (1971) and Johnson et al. (1975) have shown that multiple 
births may be induced from a synchronized estrus. 
The results obtained in these previous studies stimulated the 
present trial which was designed to examine the endocrine response of the 
beef female to injections of PMSG. How-ever, since very little informa-
tion is available concerning the endocrine status of the cow after she 
has been treated with PMSG, this review will also be concerned with the 
hormone levels found in the nonpregnant normal cow during the estrous 
cycle. 
Bovine Estrous Cycle 
The bovine estrous cycle may be divided into four basic periods; 
namely, proestrus, estrus, metestrus and diestrus. Proestrus (the folli-
cular phase) is characterized by rapid growth of the follicle and usually 
lasts two or three days. Proestrus is followed by the period of estrus, 
the time in which the female is sexually receptive to the male and mat-
ing occurs. The period of estrus usually lasts only a short time aver-
aging approximately 17 hours in the cow and slightly less in the heifer 
(Trimberger, 1948). In the cow, ovulation occurs and the ·corpus luteum 
begins to form during metestrus. The uterus prepares for implantation 
and is primarily under the influence of progesterone during diestrus (the 
luteal phase). The ·entire estrous cycle usually spans about 21 days in 
the cow, while the cycle of the heifer may be slightly shorter 
(Desjardins and Hafs, 1968; Swanson et al., 1972). 
Endocrine Status During the Estrous Cycle 
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The development of specific :and sensitive radioimmunoassays for the 
protein and steroid hormones has greatly stimulated the study of endocrine 
changes associated with the bovine estrous cycle. 
Follicle-Stimulating Hormone (FSH) 
Follicle-stimulating hormone is a glycoprotein with a molecular 
weight of approximately 30,000. The carbohydrate ·content of the molecule 
·amounts to 27% of the FSH molecule and sialic acid comprises 5% of its 
weight. The carbohydrate moiety seems to be ·es·sential for the biological 
activity. FSH is produced by the basophilic staining cells of the anter-
ior pituitary gland and its release is probably mediated through hypotha-
lamic releasing factors. The activity of FSH in the female is to promote 
growth and development of follicles in the ovary. In addition, it will 
also stimulate increased oxygen uptake ·and protein synthesis in the ·theca 
cells (Baird, 1972). 
Early investigations into the functioning of FSH dealt primarily 
with pituitary levels of the hormone since no assay was available for 
quantifying it in the peripheral circulation. The great.est fluctuation 
in pituitary FSH occurs near the time of .estrus. Rahka and Robertson 
(1965), using .the ovarian weight augmentation method of Steelman and 
Pohley (1953), found that the pituitary content of FSH decreased approx-
imately 27% b:etween the beginning and the -end of estrus in the cow. 
These results were substantiated by Desjardins and Hafs (1968). In 
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addition, Hackett and Hafs (1969) showed a 49% decrease in pituitary FSH 
between days 18 and 20 of the cycle. More recently Akbar et al. (1974) 
have reported a specific radioimmunoassay for bovine FSH using .rabbit 
anti-serum to ovine FSH and radioiodinated human FSH. These workers re-
ported that serum FSH values for cycling heifers tended to be higher on 
the day of estrus but was not signific:antly different from levels ob-
served during other stages of the cycle when samples were drawn at daily 
intervals. However, when samples were collected ·at two hour intervals, 
the highest level of FSH cdincided with the LR peak and was significantly 
different from the levels measured before or after the LR p:eak. 
Luteinizing Hormone (LR) 
As was the case with FSH, lute·inizing hormone .is a glycoprotein 
molecule containing less sialic acid than that reported for FSH. LR is 
also produced by the basophilic staining cells of the ~nterior lobe -0f 
the pituitary gland. LR activity in the female involves several distinct 
actions including the stimulation of steroid synthesis from all cell types 
in the ovary. Hoffman et al. (1974) have suggested that LR may be the 
primary luteotrophic factor in the bovine species. LR also promotes a 
rapid and large increase in ovarian blood flow probably increasing the 
supply of the critical metabolites needed by the ovary for its proper 
functioning. Also, if follicles have been properly primed with FSH, LR 
will induce ovulation (Baird, 1972). 
The primary activity of LR is focused around the time of estrus but 
occurs about two days after the primary effects of FSH on the ovary have 
been exhibited. Rahka and Robertson (1965), Anderson and McShan (1966) 
and Desjardins and Hafs (1968) observed decreased pituitary LR during 
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estrus which suggested an elevation in plasma LH. Hackett and Hafs 
(1969), using the ovarian ascorbic acid depletion (OAAD) method of Parlow 
(1961), demonstrated a rapid reduction in pituitary LH around estrus 
which coincided closely with increased levels of LH in the blood reported 
by Hansel and Snook (1970) and Swanson and Hafs (1971). Since the advent 
of a specific radioimmunoassay for LH (Niswender et al., 1969), several 
studies have been reported concerning the amounts of LH in the blood of 
cows during the estrous cycle. Notably among these, Swanson and Hafs 
(1971) conducted an extensive trial whereby they evaluated LH and prolac-
tin in blood serum from estrus to ovulation in Holstein heifers. Their 
work showed that serum LH began a continuous but nonsignificant rise five 
days before estrus which was followed by a highly significant peak of LR. 
The peak preceeded the onset of standing .estrus by about three hours. LH 
remained elevated for six to eight hours, and ovulation occurred 32 hours 
after the LH peak. They also demonstrated that serum LH returned to pre-
estrual levels within four to six hours after the peak. Similar findings 
for LH values around the time of estrus have been reported by Hendricks 
et al. (1970) and Akbar et al. (1974). Similarly, Lemon et al. (1975) 
reported that plasma LH remained at low levels (2 to 4 ng/ml) until it 
peaked at 30 to 35 ng/ml before decreasing again to basal levels over a 
10 to 12 hour period. The LH peak was closely synchronized with the 
onset of sexual receptivity. 
Pro lac tin 
Prolactin is a single polypeptide chain containing about 211 amino 
acid residues and having a molecular weight of approximately 24,000 
(Baird, 1972). It is generally considered to be produced by the 
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acidophilic staining cells of the anterior pituitary, and its role in 
reproductive physiology remains obscure. Prolactin has been implicated 
along with ACTH, growth hormone, estrogen and progesterone in the initia-
tion and maintenance of milk secretion. It has also been suggested that 
prolactin is involved in the maintenance of the corpus luteum in some 
species, notably the rat; however, Hoffman et al. (1974) have suggested 
that prolactin may not serve this function in the bovine. Highly vari-
able levels of prolactin have been reported during the bovine estrous 
cycle. Sinha and Tucker (1969), using the pigeon crop sac "micro" method 
of Reece and Turner (1937), noted a significant decrease in pituitary 
prolactin from estrus until two days later. Swanson and Hafs (1971) re-
ported that serum prolactin began a sustained rise during the four days 
preceding estrus and then decreased. They noted, however, that due to 
the large variation between heifers, this increase only approached signi-
ficance. This simultaneous decrease in prolactin in the serum and the 
pituitary would seem to indicate that both synthesis and release of pro-
lactin must be affected during and immediately following estrus (Swanson 
and Hafs, 1971). In addition, these same workers noted that both LR and 
prolactin increased during the morning and afternoon and were lower at 
noon and during the night suggesting a diurnal change in these two hor-
manes. 
Progesterone 
Progesterone is a steroid hormone produced in large amounts by the 
corpus luteum and in smaller quantities by the granulosa cells of the 
ovarian follicle before ovulation and by the adrenals. Progesterone is 
generally considered to be of prime importance in the maintenance of 
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pregnancy. Early studies on this steroid hormdne dealt primarily with 
examining the corpora lutea of cycling cows as evidenced by the work of 
Mares et ~al. (1962) in which they reported a significant increase in the 
corpus luteum concentrations of progesterone .from day seven to day 15 
which was followed by a significant drop at day 17 of the estrous cycle. 
These workers assayed progesterone according to the method of Loy et al. 
(1960) involving column and paper chromatography followed by ultra-violet 
spectrophotometry. In an extensive review, Gomes and Erb (1965) noted 
that luteal progesterone was lowest at estrus ana gradually increased to 
peak levels at days 14 to 15. The concentration of progesterone in the 
ovarian vein followed the same pattern (Gomes et al., 1963). Similar 
results were ·also reported for progesterone in the peripheral blood by 
Plotka et al. (1967), Stabenfeldt et al. (1969), and Sprague et al. 
(1971). In addition, Swanson et al. (1972) and Lemon et al. (1975) re-
ported that the peak level of progesterone in heifers (8 to 10 ng/ml) 
occurred three days prior to estrus; while at the time of estrus, proges-
terone ranged from undetectable to 1.0 ng/ml. These results compare 
favorably with those reported by Kazama and Hansel (1970), Wettemann et 
al. (1972), and Glencross et al. (1973). 
Estrogen 
Estrogen is a ~ollective term used to describe a class of steroid 
hormones which includes estradiol, estrone ·and estriol. This group of 
hormones is generally considered to h~ve profound effects on the psycho-
logical manifestations of he·at as well as the development of secondary 
sex characteristics in the female. Estrogens can be synthesized by 
several tissues including the ovary, adrenal and placenta with the 
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primary source being the ovary during the bovine estrous cycle. Short 
(1962) demonstrated that estradiol 17B v/as the major estrogenic steroid 
in the follicular fluid of the cow. He ·also noted that estrone was pre-
sent but in much smaller amounts; however, estriol has not been found in 
the bovine ovaries (Mellin and Erb, 1965) but may be found in the plasma 
and urine and is thought to be ·an oxidation product (Kutsky, 1973). 
Short (1962) also noted that higher levels of estradiol-17B were found in 
preovulatory follicles than in follicles at other stages of the estrous 
cycle. In addition, England et al. (1973) have reported the presence of 
estradiol 170( in some bovine follicles. 
Early studies on estrogens were largely concerned with urinary 
concentrations since ·adequate laboratory techniques were not available 
to evaluate serum levels. Estrogens do not appear to be stored in the 
body but rather are excreted as metabolites with a major route of excre-
tion being the feces (Mellin and Erb, 1965). Since the feces:urine 
·excretory ratio seemed to be quite constant, most investigators measured 
urinary levels. However, since the advent of radioimmunoassay, several 
investigators have reported estrogen levels in bovine plasma throughout 
the estrous cycle. In a rather extensive study, Wettemann et al. (1972) 
evaluated the estradiol content in the plasma of Holstein heifers. They 
found that estradiol was lowest on the second day of the cycle and re-
mained at this low level through day 11. Estradiol then increased 
slightly three days before estrus and continued to rise to 9.7 pg/ml 0.5 
days before estrus. Estradiol remained high on the day of estrus and 
then declined to baseline levels. Similar findings were reported by 
Echternkamp and Hansel (1973) who noted that the estradiol concentration 
began to rise two to three days prior to estrus but declined rapidly 
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after estrus. They also noted that changes in plasma estrone levels 
paralleled those for estradiol, while Glencross et al. (1973) suggested 
that estrone levels were much lower and showed less variation than estra-
diol. Christensen et al. (1971) reported similar trends for total estro-
gens but their values were much higher. Further, Wettemann et al. (1972) 
noted that elevated estradiol preceded the ovulatory LH peak by one or 
two days suggesting that estrogen secretion may regulate LH release in 
cattle. These data were again substantiated by the findings of Christen-
sen et al. (1971). In addition, Echternkamp and Hansel (1973) have sug-
gested that regression of the corpus luteum appears to be essential for 
maximal estradiol secretion prior to estrus, since estradiol levels rise 
only after progesterone values decline. Finally Christensen et al. (1971), 
Glencross et al. (1973) and Dobson and Dean (1974) observed not only in-
creased estradiol one day before estrus but a second increase six days 
after estrus which is consistent with the suggestion of Rajakoski (1960) 
concerning midcycle follicular growth in some cows. 
Endocrine Status After PMGS 
Pregnant mare serum gonadotrophin is a glycoprotein molecule with a 
molecular weight of approximately 70,000 (Turner, 1966). Potencies of 
different sources of PMSG are routinely determined by using the bioassay 
method of Cole ·and Erway (1941) whereby ovarian weights from immature 
rats treated with the unknown substance are compared to weights obtained 
from animals treated with an International PMSG Standard. Cole and Hart 
(1930) reported that PMSG first appears in the blood of mares between 
the thirty-seventh and the forty-second day of pregnancy and reaches peak 
concentrations between the fiftieth and seventieth days of gestation. It 
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can be extracted from the blood and endometrial cups of the pregnant mare 
and has properties of both FSR and LR, being primarily FSH in activity. 
Turner (1966) reported that PMSG cannot be separated into its two enti-
ties; thus, any discussion of its hormonal effects must relate to its 
dual capabilities. In addition, PMSG remains in the blood and lymph and 
is practically absent from the urine giving rise to its more prolonged 
effect than that seen from human chorionic gonadotrophin (RCG) or puri-
fied extracts of either FSR or LR (Turner, 1966). Onuma et al. (1969) 
suggest that PMSG may be more effective than FSR in eliciting a super-
ovulatory response in the calf due to the tough follicular walls noted 
after FSR treatment.which may possibly be caused by insufficient LR in 
the FSR preparation. 
Superovulation of the Prepuberal Female 
There are many potential benefits to be gained from superovulation 
of prepuberal calves. These would include the genetic benefits from ovum 
transfer to reduce the generation interval and progeny testing of females. 
Casida et al. (1943) showed that superovulation in calves can be induced 
by hormone treatment. A recent report by Onuma et al. (1970) has sum-
marized much of the current work in this area. 
To dramatize the efficiency with which prepuberal calves can be 
induced to ovulate using PMSG, one need only to examine the work of 
Seidel et al. (1971). These investigators found that treatment of calves 
with 1500 I. U. PMSG followed by 50 mg of LR five days later produced an 
average of O, 9.4, and 28.2 ovulations in calves 0, 1, and 2 months old. 
By five months of age, 1500 to 2000 I. U. PMSG and 75 mg of LR produced 
77.2 ovulations per calf. In a similar study using Holstein calves from 
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9 to ll weeks of age, Onuma et al. (1969) found that treatment with FSH 
resulted in 3.8 ovulations while 15.4 ovulations were observed after PMSG 
injections. These workers also noted that follicular and ovulatory re-
sponse appeared to decline with repeated administration of gonadotrophin 
suggesting the development of a refractoriness to the hormones. 
However, there is only limited data available regarding endocrine 
changes in the calf after PMSG. Spilman et al. (1973) injected 47 Hol-
stein calves from two to five months of age with 1250-2000 I.U. PMSG 
followed five days later by 75mg LR. They then measured pituitary LR by 
the ovarian ascorbic acid depletion test and plasma LR by radioimmunoas-
say (RIA), with no cross reactivity being found between PMSG and the LR 
antibody used in the RIA. Plasma and luteal progesterone were quantified 
using thin layer and gas liquid chromatography. After superovulation, 
pituitary LR values decreased significantly compared to control values 
and remained low. Plasma LR values rose sharply on the day after PMSG 
injection and declined gradually to pretreatment levels. The suggestion 
was made that this rise in LR reflects endogenous release of LR following 
estrogen secretion by PMSG-stimulated follicles. However, these workers 
did not measure estrogen levels in these animals. They noted that super-
ovulation was followed by production of fully functional luteal tissue 
and that luteal progesterone levels after induced ovulation were main-
tained approximately eight days longer than in normally cycling cattle. 
Plasma progesterone levels were also high presumably as a result of the 
large mass of active luteal tissue present. The correlation between peak 
plasma progesterone and number of corpora lutea was 0.76. Progesterone 
was not detected in blood samples from a calf that failed to ovulate, 
leading to the conclusion that the treatment regimen did not cause 
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progesterone production in the absence of luteal tissue. In a separate 
experiment, Spilman et al. (1972) demonstrated that corpora lutea from 
prepuberal cattle incubated in vitro in the presence of LR increased their 
production of progesterone by 27 percent. One wonders if the addition 
of PMSG to the incubation medium would have a similar luteotrophic effect 
to the point that injections of PMSG early in the cycle could cause main-
tenance of the corpus luteum. 
Superovulation of the Post-Puberal Female 
Hammond (1949) reported that multiple ovulations and multiple 
pregnancies could be induced with single injections of PMSG although 
there was much variability in ovulation rates. Schilling and Holm (1963) 
observed a preponderence of two to three corpora lutea following a se-
quence of two PMSG injections, and similar results were reported by Laster 
et al. (1971). Several problems associated with induced superfetation in 
cattle have been noted including lowered conception rates (Schwartz and 
Shelby, 1969), retained placentas and freemartinism (Turman et al., 1971). 
The most difficult problem to overcome, however, has been that of trying 
to limit ovulations to an acceptable number. An understanding of the hor-
monal changes in the cow after she has been injected with PMSG might 
prove beneficial in this regard. 
Spilman et al. (1973) noted that pituitary concentration of LR in 
six postpuberal heifers superovulated by PMSG was 1.1 mg LR per gram of 
pituitary. These results compare favorably with Desjardins et al. (1966) 
who found pituitary LR of sexually mature cattle to be about 2 mg per gram 
of fresh tissue. Spilman et al. (1973) also noted that plasma LH in 
sexually mature cycling heifers rose sharply after PMSG and declined 
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gradually thereafter to values similar to normally cycling cattle. As 
was the case with prepuberal calves, luteal progesterone in some of the 
superovulated mature heifers was maintained approximately two to three 
days longer than in normal cycling heifers. The level of plasma proges-
terone in heifers treated with PMSG on day 15 or 16 was also substantially 
higher than those reported in normal cows during the estrous cycle. Simi-
larly, equine luteinizing hormone caused a significant increase in pro-
gesterone levels in heifers (Brunner et al., 1969). 
Hendricks and Lamond (1972) showed that after administering PMSG 
plasma estrogen and LH levels were greater in cows which subsequently had 
multiple ovulations than in cows having one ovulation. In a more exten-
sive trial, Hendricks et al. (1973) allotted 24 beef heifers to one of 
three treatment groups. The animals received either 0, 1600 or 3200 I. U. 
PMSG on day 16 of the estrous cycle. Plasma estrogen, LH and progesterone 
were quantified by RIA from blood samples collected from day 16 until 12 
hours after the onset of estrous. They noted that most ovulations were 
associated with the longest interval between PMSG injection and estrus in 
the heifers treated with 1600 I.U. but not in those treated with 3200 I.U. 
PMSG. They also observed that five of the eight heifers receiving 3200 
I.U. PMSG had large numbers of cystic-appearing follicles. Plasma pro-
gesterone began to decrease about 60 hours before estrus in the 0 and 
1600 I.U. groups and about 36 hours before estrus in the 3200 I.U. group. 
Progesterone was less than 1 ng per ml for 24 hours, 12 hours and 6 hours 
before estrus in the 0, 1600 and 3200 I. U. groups, respectively. Plasma 
progesterone remained elevated for a longer period of time in the 3200 
I.U. group but decreased at a more rapid rate before estrus. The mean 
rates of increase in plasma estrogen were 0. 08, 1. 0 and 1. 2 pg per ml per 
16 
hour for the 0, 1600, and 3200 I.U. groups, respectively. Plasma estrogen 
was not correlated with follicle number or maximum plasma LR. In the PMSG 
treated groups, plasma LR began to rise about six hours prior to estrus 
and peaked at the time estrus was detected. In the control group, how-
ever, LR did not begin to rise until after estrus was detected and did 
not peak until six hours later. Since there was no correlation between 
number of ovulations and the LR peak, it suggests that there was enough 
LR for ovulation. Guthrie et al. (1974) reported a similar study in swine 
in which plasma estrogen, LR and progesterone were examined in mature 
gilts after an injection of 0, 1600 or 1200 I. U. PMSG on day 15 of the 
estrous cycle. Plasma estrogen for gilts receiving 1200 I.U. PMSG was 
significantly greater than the means for the other two groups on the day 
before estrus and on the first day of estrus. Plasma progesterone was 
also higher four and three days prior to estrus in animals receiving PMSG. 
The magnitude of the preovulatory LR surge, however, was not significantly 
affected by PMSG treatment. 
In a similar study, Lamond and Gaddy (1972) treated 48 heifers with 
1500 to 3000 I.U. PMSG in two separate trials. They were interested in 
examining the progesterone values in the heifer having multiple ovulations. 
Blood samples were collected at five day intervals beginning 15 days after 
mating. The results were variable, but generally the heifers having in-
creased numbers of ovulations also had increased plasma progesterone 
levels. Regression analyses suggested that each additional corpus lutet.m 
resulted in an increase of 8.0 ± 2.14 and 9.2 ± 2.50 ng progesterone/ml 
for the two trials, respectively. These authors postulated that cows with 
the highest probability of carrying a small little to term may be those 
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which are able to limit blood progesterone concentrations to physiological 
ranges. 
Response to Repeated Injections of PMSG 
Willett et al. (1953) suggested that repeated injections of 
gonadotrophins lead to a refractory state by demonstrating that the num-
ber of corpora lutea in cattle decreased with successive superovulations. 
These authors suggested three possible explanations for this refractori-
ness: development of an antisubstance to the gonadotrophin, exhaustion 
of primary follicles in the ovaries or varying degrees of damage to the 
ovaries as a result of the treatments or surgery. They suggested further 
that increased responses of some cows to increased doses of hormones 
gave credence to the antigonadotrophin concept; while the progressive 
decline in the number of corpora lutea in one cow in spite of alternating 
species as sources of FSH indicated the contrary. When they assayed the 
blood serum from some of the refractory cows for antigonadotrophin using 
a rat bioa,ssay described by Deutsch et al. (1950), they found that the cow 
serum augmented the ovarian response of rats to gonadotrophins instead 
of inhibiting it. Casida et al. (1943) also found only slight evidence 
of antihormone in serum from cows given large daily doses of sheep pitui-
tary extract. 
Hafez et al. (1964) were unable to induce multiple ovulations in cows 
with repeated injections of PMSG. Jainudeen et al. (1966) endeavored to 
determine the ovarian response to repeated doses of PMSG and to examine 
the serums of the cows for antigonadotrophic activity in immature female 
rats using the method of Cole et al. (1957). These workers gave a series 
of PMSG injections on day 16 of four different estrous cycles with five 
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to seven months between the first and second injections after which two 
and one estrous cycles separated subsequent injections. Their results 
also indicated that ovarian response was altered by repeated PMSG injec-
tions. However, in contrast to previous studies, their data showed an 
inhibitory influence of 2 ml of serum from cows treated with PMSG on the 
ovarian response of immature female rats suggesting the presence of an 
antigonadotrophic substance. Their work also suggests that the antigon-
adotrophic substance may persist from seven to eight months; while Thomp-
son (1941) considers antigonadotrophic activity in blood serum to be 
usually lost one or two months after termination of injection of the hor-
mane. 
Greenwald (1970) reported a similar refractory period in the rabbit 
after repeated injections of human chorionic gonadotrophin (HCG). How-
ever, some rabbits that were refractory to HCG were mated and subsequently 
ovulated indicating that any antiserum against HCG that was present did 
not neutralize endogenous LR. 
CHAPTER III 
MATERIALS AND METHODS 
Procedure 
General 
This study was conducted from Jaq.uary, 1974 to May, 1975 at the Fort 
Reno Livestock Research Station, El Reno, Oklahoma, and the Animal Science 
Physiology Laboratory on the Oklahoma State University campus in Still-
water. The experiment-al animals consisted of 54 straightbred Angus fe-
males including 31 three year-old lactating cows raising their first calf 
and 23 two year-old heifers. All cows had been treated with PMSG during 
the previous reproductive cycle while none of the heifers had received 
prior hormonal therapy. All animals exhibited at· least one normal estrous 
cycle before being allotted to a treatment group. They were maintained 
on native pasture ·at a moderate level of winter feeding which required 
providing approximately 1.4 kg of a 30 percent natural protein supplement 
per day between January 1 and April 15. 
Assay, Storage and Administration of PMSG 
The pregnant mare serum gonadotrophin (PMSG) used in this study was 
obtained as a lyophilized powder with a stated potency of 200 T. U. PMSG 
per mg. Prior to use in this trial, the PMSG was assayed according to 
the method of Cole ·and Erway (1941). The assay was carried out in 21 
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day old immature female rats of the Texas Inbred Mice Company strain, 
Tex:SD (Sprague-Dawley Derived). The standard PMSG preparation used was 
the World Health Organization Second International Standard for Serum 
Gonadotrophin, Equine (Medical Research Council, Division of Biological 
Standard, National Institute for Medical Research, Hampstead Laboratories, 
Holly Hill, London NW36RB). Fifty rats received a single subcutaneous 
injection of 0.5 ml saline containing either 4, 6, 9, 13 or 20 I.U. of the 
International Standard or the PMSG used in this trial while five rats 
served as saline injected controls. The rats were sacrificed 48 hours 
later and wet ovarian weights determined. The mean ovarian weights of 
the five rats in each treatment group are presented in Table I. An anal-
ysis of variance utilizing a 2 x 5 factorial -arrangement of treatments 
(Snedecor and Cochran, 1967) yielded no evidence to suggest that the test 
PMSG differed significantly in potency (P ) • 25) from that of the Inter-
national Standard. In addition, 4 I. U. of both the test and the Standard 
PMSG produced significantly (P <. .05) larger ovaries than those seen in 
saline treated controls. Therefore, the stated potency of 200 'I.U. PMSG 
per mg was used in preparing hormone injections. 
The lyophilized PMSG was sealed in bottles and stored at -10 C to 
protect against damage from heat or moisture. Near the time of injection, 
individual d.oses of PMSG were weighed, placed in 15 ml test tubes, 
stoppered and refrigerated in the physiology laboratory at Fort Reno. 
Just prior to being injected, the PMSG was reconstituted with six ml of 




MEAN OVARIAN WEIGHTS OF IMMATURE FEMALE RATS 
TREATED WITH EITHER THE SECOND 
INTERNATIONAL STANDARD FOR 
SERUM GONADOTROPHIN 
(STANDARD) OR THE 
PMSG USED IN 
THIS TRIAL 
(TEST) a 
I. u. PMSG 
4 6 9 13 
21 
20 
Standard 43.5+2.6b 42. 9+1.4 58. 7±1. 8 61.6+3.4 68.3+5.0 
Test 37.4±2.0 47.2±4.1 59.o+5.0 59.7+1.6 73.5±7.l 
aValues are mean± S. E. from five rats on each treatment 
bvalues are expressed in milligrams 
Treatments 
The treatments imposed in this study were utilized to compare the 
endocrine and reproductive responses of cows and heifers treated with 
PMSG either during the late luteal phase or both during the early and 
late luteal phases of the estrous cycle. Table II illustrates the treat-
ment schedule used to pursue these objectives. Sixteen cows and ll 
heifers received a single subcutaneous injection of 2000 I. U. PMSG on 
day 17 (day 0 = estrus) of their estrous cycle; while 15 cows and 12 
heifers received 1500 I. U. PMSG on day 5 followed by 2000 I. U. PMSG on 
day 17. Estrus was determined by using vasectomized or penectomized 
bulls equipped with chinball markers. 
Items 
Day of Cycle 
Day 5 
Day 17 







2000 I. U. PMSG 
16 cows 
ll heifers 
Treatment 5, 17 
1500 I. U. PMSG 
2000 I. U. PMSG 
15 cows 
12 heifers 
All animals were bled at regular intervals during the estrous cycle 
in which PMSG treatments were imposed. Blood samples were obtained by 
jugular venipuncture using a l~ inch 16 gauge needle and a 50 cc syringe 
in the morning of days 1, 3, 5, 6, 7, 9, 11, 13, 15, i1, 18 of the cycle, 
then daily until estrus occurred, or until day 26 if estrus did not occur. 
Blood was transferred from the syringe to a plastic centrifuge tube con-
taining 31. 7 mg oxalic acid and centrifuged at 2700 x g for 15 minutes 
to remove the blood cells. The plasma was then decanted into 7-dram 
plastic vials and stored at -10 C until assayed for hormone concentration. 
At the first estrus after the last PMSG injection, all animals were 
bred by natural service to Angus bulls. A final blood sample was col-
lected approximately 12 days after breeding. 
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Laparotomy Technique 
In order to determine the number of ovulations resulting from PMSG 
treatment, a high lumbar laparotomy (Laster, 1971) was performed on each 
animal approximately seven to 11 days after breeding. The laparotomies 
were performed on the animal's right side between the last rib and the 
external angle of the ilium. The hair was clipped and the entire opera-
tive ·area was scrubbed with antiseptic soap (Roccal-D). The skin and 
underlying tissues were anesthetized by injecting a total of 20 ml of tw:> 
percent procaine in two ml quantities along either side of the incision 
line. Prior to surgery all instruments and the hands and forearms were 
scrubbed with antiseptic soap. An eight inch vertical incision was made 
through the skin beginning approximately four inches below the lumbar 
vertebrae. A slightly shorter incision was then made through the outer 
muscle layer. The inner muscle layer was pierced by placing the fore-
finger between the muscle bundles and forcing the hand through the layer. 
A small incision was then made in the peritoneum and the hand and forearm 
were forced into the body cavity. Hemorrhage was controlled by clamping 
hemostats on the severed blood vessels. 
Once the ovaries had been located, they were grasped with the hand 
and observed through a laparoscope (Jacobs-Palmer Operating Peritoneo-
scope, Richard Wolf Medical Instruments Corp., 7046 Lyndon Ave., Rosemont, 
Illinois 60018) inserted into the body cavity. Ovarian size, number of 
corpora lutea, number of follicles and the presence of any abnormal 
structures such as cystic follicles were noted for each ovary. The cut 
tissues were. closed in the reverse order that they were entered, and the 
operative ·area was covered with iodine. Following the laparotomy, each 
24 
animal received an intramuscular injection of 8 ml Pestrep. After the 
entire treatment regimen had been completed, all animals were placed on 
native grass pasture with fertile bulls for a period of 60 days after 
which pregnancy rates were determined by rectal palpation. 
Radioimmunoassays (RIA) 
A series of radioimmunoassays were conducted on each plasma sample. 
A detailed description of the assays used to quantify 'plasma progesterone, 
estradiol and lute'inizing hormone will follow in subsequent sections. 
Progesterone 
Plasma progesterone was quantified by RIA similar to the method 
described by Kittok et al. (1973). The specificity of the antiserum 
(11869) used in these determinations has been reported in detail (Niswender, 
1973). 
To minimize background interference in this assay, all glassware 
was washed prior to use with detergent and rinsed in tap water, distilled 
water, glass distilled water and methanol. In addition, all glassware 
was also rinsed with 5% trimethyl chlorosilane in toluene. One ml plasma 
was placed in a 15 ml screw c-ap extraction vial, followed by the addition 
of 3000 dpm of 3H-l,2,6,7 progesterone (New England Nuclear; 105 c/rriM.; 
repurified by column'chromatography; solvent was chloroform:ethanol; 
95: 5, V:V; Swanson et al., 1971). The plasma and tracer were mixed 
gently and allowed to equilibrate for 15 min. at room temperature. Plasma 
and tracer were then extracted with 10 ml benzene:hexane (1:2, V:V) by 
vigorous inversion for 15 minutes. Samples were placed at -10 C for at 
least one hour to fre-eze the plasma. The solvent extracts were decanted 
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into 12 ml conical test tubes and evaporated under nitrogen to 
approximately 3.0 ml. A 0.5 ml aliquant was taken to estimate procedural 
losses, and dilution duplicates appropriate ·for the expected amount .of 
progesterone present were placed in 12 x 75 mm disposable culture tubes 
and dried under nitrogen. 
Standards were diluted in 200 proof redistilled ethanol so that 0.1 
ml contained 0, 0.1, 0.2, 0.3, 0.4, 0.6, 0.8, and 1.6 ng of progesterone. 
Two standard curves were used in each 48 tube assay, and these were also 
dried under nitrogen. In addition, a steer sample and a steer plus five 
ng progesterone were ·also used in each assay. 
After the standard and plasma extracts were evaporated, 0.2 ml 
antibody (Anti-progesterone 11869 generously supplied by Dr. G. D. Niswen-
der, Department of Physiology, Colorado State University, Fort Collins) 
against 6B-succinyl progesterone conjugated to bovine serum albumin was 
added to each tube, mixed gently and allowed to equilibrate ·at room tem-
perature for 15 minutes. The antibody had been diluted 1:6000 in 0.1 M 
phosphate buffered saline containing 0.1% gelatin (Knox Gelatin, Inc., 
Johnstown, N.Y.; Table VII). Following the incubation period, 0.2 ml of 
0.1% gelatin in 0.1 M phosphate buffered saline containing approximately 
58,000 dpm of 3H-l,2,6,7-progesterone was added to each tube. The tubes 
were mixed gently and incubated at 4 C for 12 to 20 hours. 
Following the overnight incubation, the tubes were placed in an ice 
water bath at 4 C for 10 minutes after which one ml dextran coated char-
coal (2.5 g activated neutral norit plus 0.25 g dextran T-150 in one liter 
glass distilled water) was rapidly (less than two minutes) added to each 
tube. The contents were mixed, incubated for 10 min. at 4 C and centri-
fuged (1200 x g) at 4 C for 10 minutes. A 0.5 ml aliquant of the 
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supernatant was diluted with 10 ml of liquid scintillator (21.7 g 2, 5 
diphenyl oxazole in 3.0 liter toluene) for quantification of radioactivity 
in a Packard Tri-Carb Liquid Scintillation Spectrometer. The mass of 
progesterone in unknowns was calculated by interpolation between standards 
and corrected for procedural losses. 
Kittok et al. (1973) demonstrated the specificity of this assay by 
comparing it to a competitive protein binding assay and to radioimmuno-
assay of progesterone isolated by Sephadex LH-20 column chromatography. 
Since these results indicated a high degree of specificity in this assay, 
no further validation was carried out in our laboratory. However, 34 
determinations were conducted on a pool of steer plasma and averaged .28 
± .01 ng/ml. In addition, an average of 5.03 ± .09 ng/ml (95% recovery) 
was obtained from 44 determinations of a steer plasma+ 5 ng progesterore/ 
ml resulting in a between assay coefficient of variation of 12.04%. 
Finally, the addition of 0.1 ng progesterone to the assay resulted in 
approximately a 30% reduction in the amount of 3H-progesterone that was 
bound to the antibody indicating that this assay is highly sensitive at 
the lower hormone concentrations. 
Estradiol 
The procedure used to quantify estradiol was similar to that 
described by Wettemann et al. (1972) as modified by Hafs et -al. (1974). 
Triplicate aliquan'l:s (LO ml) of plasma were placed in 13 x 100 mm dis-
posable culture tubes which had been rinsed with redistilled methanol. 
Approximately 3000 dpm of 3H-2,4,6,7-estradiol (111 c/niM; repurified by 
column chromatography) in ethanol was added to one of the triplicate 
tubes, vortexed gently and allowed to equilibrate for 30 minutes. 
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Estrogens were extracted by vortexing with 3.0 ml benzene (Nanograde) 
for one minute. Solvent from the tracer tube was pipetted into a scin-
tillation vial to estimate procedural losses; while the solvent from the 
other two tubes were pipetted into 12 x 75 mm disposable culture tubes 
for radioimmunoassay. Standards were diluted in redistilled ethanol so 
that 0.1 ml contained O, 1, 2, 4, 6, 10, 20, 40, 60 and 100 pg estradiol. 
Two standard curves were placed with each assay (48 total tubes per 
assay), and the standards and solvent extracts were evaporated under 
nitrogen. In addition, a water blank and a cow reference sample were 
also placed in each assay. 
After evaporation 0.2 ml antibody (Antiestradiol 11244 generously 
supplied by Dr. G. D. Niswender, Colorado State University) against 6-B 
succinyl estradiol conjugated to bovine serum alubmin was added to each 
tube, vortexed gently and incubated at room temperature for 30 minutes. 
The antibody had been diluted 1:100,000 in phosphate buffered saline 
plus 0.1% gelatin (Table VII). 3 Approximately 30,000 dpm H-2,4,6,7-
estradiol (111 c/niM) in O. 2 ml phosphate buffered saline plus 0.1% gela-
tin (Table VII) was then added to each tube, vortexed gently and incubated 
I 
at 4 C for three to 20 hours. Free ·and bound estradiol were separated, 
radioactivity was quantified and mass of estradiol was calculated as 
described for the progesterone assay except that the ·assay tubes were 
centrifuged at 1600 x g for 10 min. at 4 C after the dextran coated char-
coal was added. 
Previous radioimmunoassays for estradiol had been hampered by the 
fact that many antib¢dies would cross react with other estrogens requir-
ing the·separation of the estrogens by column chromatography prior to 
radioimmunoassay. The antibody used in this experiment was believed to 
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be highly specific for estradiol, but this premise had to be validated 
before the·antiserum could be used to quantitate estradiol without iso-
lation by chromatography. 
The first step in the development of the assay was to determine the 
titer of the antibody that would result in the most desirable sensitivity 
and percent binding. The 1:100,000 dilution proved to be the most useful 
in that it resulted in approximately 19% of the competitor being bound to 
the antibody; while the addition of one pg estradiol resulted in approxi-
mately a 5% reduction in the ·amount of competitor that was bound. The 
antibody was next checked for cross reaction with various other steroids. 
When tested in this assay, estriol showed no crossreaction with the ,anti-
body, while 320 pg estrone was equivalent to about 10 pg estradiol. 
Progesterone (6.4 ng), testosterone (10 ng), cortisol (10 ng) and corti-
costerone (10 ng) also showed very little if any cross reactivity, while 
200 pg estradiol benzoate was equivalent to about 80 pg estradiol. 
Figure 1 illustrates a typical standard curve for estradiol .and cross 
reactions with estrone and estradiol benzoate as determined by RIA. 
As a further validation step, estradiol was quantified in benzene 
extracts of 14 samples (range 1. 5 to 14. 9 pg/ml) and the estimates were 
compared to those obtained on the same samples after isolation of estra-
diol from Sephadex LH-20 columns (Chenault et al., 1975; so-lvent was 
benzene: methanol; 95:5; V:V). Estradiol in the extracts (3.8 ± 1.0 
pg/ml) did not differ significantly (P ) .25) from those determined after 
column chromatography (4.6 ± 1.0 pg/ml). In addition, a significant 
positive correlation coefficient was calculated between the two methods 
(r = .95; P < .01). Similarly, the between assay coefficient of varia-
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When two, four or six pg of estradiol were added to one ·ml plasma samples, 
97 ± 7% (n = 4), 98 ± 7% (n = 4) and 106 ± 2% (n = 6), respectively, were 
recovered. 
Luteinizing Hormone (LH) 
The method used to quantify plasma LH was similar to that described 
by Niswender et al. (1969) as was the radioiodination procedure except 
125I rather than 1~I was used. Purified bovine LH used for iodination 
(LER 1072-2) was supplied by Dr. Leo Reichert (Emory University, Atlanta, 
Georgia). Plasma samples were assayed in dilution duplicate such that 
0.2 and 0.3 ml plasma were added to 12 x 75 mm disposable culture tubes 
containing 0.3 and 0.2 ml phosphate buffered saline plus 0.1% gelatin, 
respectively (Table VII). 
Bovine LH (NIH-LH-B8) was used as the standard in the ·assays. 
Standards were diluted in phosphate buffered saline plus 0.1% gelatin 
(Table VII) so that 0.5 ml contained 0, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 
6.4, 12.8, and 25.6 ng LH. Three sets of standards were included in each 
assay of 300 to 400 tubes. Two hundred ul of an antibody (Anti-LH-B225 
generously supplied by Dr. G. D. Niswender, Colorado State University, 
Fort Collins, Colorado) against bovine LH was added to each tube, vor-
texed gently and incubated at 4 C for 24 hours. The antibody was diluted 
1:80,000 in 1:400 normal rabbit serum which had been suspended in 0.05M 
phosphate buffered· saline plus EDTA (Table VII). On the following day, 
0.1 ml of approximately 20,000 cpm 125I-LH in phosphate buffered saline 
plus 0.1% gelatin (Table VII) was added to each tube vortexed gently and 
incubated for another 24 hours at 4 G. Two hundred ul of an appropriate 
dilution of a second antibody (sheep anti-rabbit gamma globulin) against 
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rabbit gamma globulin fraction II (Nutritional Biochemical Corp., 
Cleveland, Ohio) was then added to each tube to insure that the LR-anti-
LR complexes would be precipitable. The second antibody was usually 
diluted 1:6 in phosphate buffered saline plus EDTA (Table VII). Each 
tube was vortexed gently a final time ·and then incubated at 4C for 72 
hours. After the final incubation period, three ml of cold phosphate 
bQffered saline was added to each tube, and the free -and bound LR were 
separated by centrifugation at 2300 x g for 30 minutes at 4 C. The 
supernatant was carefully decanted and the precipitate counted in a 
Packard Tri-Carb Liquid Scintillation Spectrometer with a tandem gamma 
unit. 
As was the case in the estradiol .assay, the specificity of the 
antibody used in this experiment for bovine LR had not been demonstrated. 
Validation of this antibody was, therefore, imperative be:fore assay of 
the unknowns could be accomplished. Several concentrations of the anti-
body were tested with the 1:80,000 dilution yielding b_etwe·en 10 and 20% 
bound 125I.:.LR as well as adequate depression at the 0.1 ng LR level 
(approximately 10% reduction). In addition, dose response curves for 
plasma from steers, cows, and anterior pituitary homogenates were parallel 
to the LR standard curve (Figure 2). Figure 3 illustrates the cross 
reaction of the antiserum with other pituitary gonadotrophins. When 100 
ng of growth hormone (NIR-GH-B17 ) and 200 ng of prolactin (NIR-P-B3) were 
tested in this assay, each had less than one ng equivalent LR; and one ug 
of follicle stimulating hormone (NIR-FSR-S 9) was equivalent to about two 
ng LR. Ten ng thyroid stimulating hormone (NIR-TSR-B6) was, however, 
equivalent to about three ng LR. Selenkow et al. (1966) and Guillemin 
(1967) have suggested that this cross reaction with TSR may be due to 
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contamination of the TSR with immunologically active LR since the two 
hormones appear to be related immunologically. 
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To estimate the precision of the LR assay, a sample from a pool of 
steer plasma was included in each assay resulting in an average of 2.1 + 
.3 ng/ml with a between assay coefficient of variation of 30.3%. Simi-
larly a series of determinations on the same sample were conducted in a 
single assay yielding an average of 0.7 + 0.03 ng/ml with a within assay 
coefficient -of variation of 10.6%. When two, four or ·six ng LR were 
·added to bovine plasma, 70.6 ± 2.5% (n = 5), 70.7 + 5.8% (n = 5) and 
58.3 ± 3.2% (n = 5), respectively, were recovered. 
Statistical Analysis 
Several analyses were conducted to adequately evaluate the data. 
Standard procedures described by Snedecor and Cochran (1967) were employed 
to examine some variables. Estrous cycle length and ovulation rate were 
analyzed by analyses of variance using completely randomized designs. 
Chi squares techniques were employed to test for significant differences 
in conception rate and percent of an:Lmals having various numbers of ovu-
lations. Simple correlation and regression coefficients were also uti-
lized to describe the relationship between the various endocrine parameters 
and number of corpora lutea. 
Endocrine data were subjected to split plot analyses of variance as 
described by Gill and Rafs (1971) for repeated measuranents on animals. 
Table III illustrates the analysis used to determine the influence of 
FMSG treatment on plasma progesterone in the cow using two between block 
treatments (PMSG) and one within block treatment (Bleeding period). When 
a significant treatment x bleeding period interaction was detected, an 
analysis of variance was utilized to evaluate treatment differences 
within a bleeding period (Snedecor and Cochran, 1967). 
TABLE III 
SPLIT PLOT ANALYSIS OF PLASMA PROGESTERONE IN 
COWS AFTER TREATMENT WITH PMSG 
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Within Animals 
Bleeding Period 
Treatment x Period 












RESULTS AND DISCUSSION 
Reproductive Response 
Overall reproductive response from the ·animals in this experiment 
was estimated by examining several variables as shown in Table IV. Ap-
proximately the same percentage of the cows in both treatment groups and 
heifers in Trt 17 exhibited estrus after PMSG injection, while all heifers 
receiving two injections (Trt 5, 17) were observed in estrus. Cows 
treated with two injections of PMSG showed a significantly longer estrous 
cycle than those treated only on day 17 (23.9 ± .5 vs 21.9 ± .7 days, 
respectively; P < .05). A similar trend was evident in the heifers with 
animals given two injections cycling in 23.6 + .5 days while heifers 
treated only on day 17 cycled in 21. 6 + 1. 1 days (P < .10). Cows treated 
twice returned to estrus in 6.9 + .5 days after the last.injection, while 
those given a single injection were in heat 4. 9 + . 7 days later (P ( • 05). 
Similarly, heifers given two injections returned to estrus in 6.6 + .5 
days, while those receiving a single injection returned in 4. 6 ± 1.1 days 
(P < .10). 
Animals conceiving to the first post-PMSG estrus as determined by 
rectal palpation 60 days after breeding or by subsequent calving dates 
are also shown in Table IV. The conception rates determined by means of 
rectal palpation for both groups of cows and for heifers on Treatment 5, 
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TABLE IV 
ESTROUS CYCLE LENGTHS, PERCENT OF ANIMALS SHCMING 
ESTRUS AND CONCEPTION RATES AFTER TREATMENT 
WITH PMSG 
Cows Heifers 
Item Trt 17 Trt 5, 17 
Animals 16 15 
Exhibiting 
Estrus (%) 75.0 66.7 
Cycle Length 
• 7b (days)a 21.9 + 23.9 + .5 
Pregnant at 60 
days (%) 62.5 60.0 
Pregnant to Trt 
at Term (%) 56.2 40.0 
aMean + S. E. 
hMeans-Differ Significantly (P < .05) 
cnifference Approaches Significance (P < .10) 
Trt 17 Trt 5, 
11 12 
63.6 100.0 







17 are similar to those reported by Turman et al. (1971) and Laster et 
al. (1971) for superovulated cows. Heifers of Treatment 17 are somewhat 
lower, but differences were not significant. Although no untreated con-
trol animals were available for comparison, the post-PMSG conception rates 
did not appear to be adversely affected which substantiates the findings 
of Hammond (1949) and Hafez et al. (1964). However, the pregnancy rates 
to the post-PMSG estrus as determined by the time of part4rition were 
somewhat lower than those determined by palpation 60 days post-breeding. 
This discrepancy was attributed to an inability to determine the date of 
conception accurately by rectal palpation. In addition, only 33% of 
those animals having multiple ovulations and conceiving to the first post-
PMSG estrus gave birth to twins. These data would tend to support the 
results of Gordon et al. (1962) and Schwartz and Shelby (1969) that both 
rectal palpation and laparotomy may be involved in embryonic mortality 
and reduced conception rates. 
Ovarian Response 
Ovarian response was determined by laparotomy seven to 11 days after 
the first post-PMSG estrus. The various ovarian measurements taken are 
shown in Table V. No significant differences were detected in total 
ovarian diarqeter in either the cow or heifer groups. In a like manner, 
all treatment groups exhibited a similar number of follicles less than 
10 mm in diameter, while cows given one injection of PMSG tended to have 
more follicles greater than 10 mm in diameter than those receiving two 
injections (2.8 ± .5 vs 1.5 ± .4, respectively; P < .10). Hendricks et 
al. (1973) reported increased ovarian weights and follicle numbers in 
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cow receiving PMSG compared to controls, but untreated animals were not 
available for comparison in our study. 
TABLE V 
OVARIANa RESPONSE ·OF ANIMALS TREATED WITH PMSG 
Item Trt 17 Trt 5, 17 
Ovarian Diameter 
(mm)h 64. 6 + 6. 7 68.6 ± 7.0 
No. Follicles 
10 mm 2.7+1.0 3.2±1.l 
No. Follicles 
10 mm ·2.8 + .5c 1.5 ± .4 
Ovulation Rate 2.2 + .4d 1.3 ± .3 
Ovulations (%) 
0 6.2 20.0 
l 37.5 60.0 
2 to 4 50.0 13.3 
> 4 6.2 6.7 
aVisual Estimates Determined at Laparotomy 
b Mean+ S. E. 
c' dDifference Approaches Significance (P < .10) 
Trt 17 
71.6+8.0 
1.4 + .4 
3. 7 + 1.4 





Trt 5, 17 
69.l ± 5.2 
2.1 ± .6 







In addition, 12.5% of the cows and 27.3% of the heifers receiving 
a single injection of PMSG had follicles that appeared to be cystic or 
luteinized, while 20% of the cows and 16.7% of the heifers receiving two 
injections had similar abnormalities. Laster et al. (1971) noted simi-
lar occurences in one of their trials as did Hendricks et al. (1973). 
Cows treated with a single injection of PMSG had a higher ovulation 
rate than those treated on days 5 and 17 (2.2 ± .5 vs 1.3 ± .3, respec-
tively; P< .10). Although the difference in ovulation rate in heifers 
was not significant (P > .25), animals treated on days 5 and 17 tended 
to have more ovulations than those treated only on day 17 (4.3 ± 1.1 vs 
3. 1 ± 1. 2, respectively). These results would suggest that animals 
treated during previous years with PMSG might respond best to a single 
injection; while animals having never received PMSG such as the heifers 
may respond adequately to either one or two injections. Laster et al. 
(1971) reported similar ovulation rates for cows receiving HCG after a 
series of two PMSG treatments, while their ovulation rates from heifers 
receiving PMSG and HCG were slightly lower than those seen in this trial. 
Percent of animals having various numbers of ovulations in also 
shown in Table V. With the ·exception of heifers given two injections of 
PMSG, one or more animals in each of the other treatment groups failed to 
ovulate. In the majority of cases, the animals that did not ovulate were 
those not showing signs of estrus. No significant differenc:es were evi-
dent between treatments within age groups for animals having only one 
corpus luteum, although 25% of the heifers compared to 60% of the cows 
receiving two injections responded with a single ovulation. Since ·all 
cows had been subjected to PMSG treatment in years past, the fact that 
43.8% of the cows given a single injection and 80% of the cows given two 
injections either failed to ovulate or shed only one ova would seem to 
lend credence to the thesis of Willett et al. (1953) that animals may 
become refractory to PMSG. 
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Fifty percent of the cows receiving a single injection an.d 13% of 
those receiving two injections had two, three or four ovulations. This 
trend was, however, reversed in the heifer group with 50% of the double 
treated heifers and 36% of the single treated having two to four egg 
ovulations. Laster et al. (1971) reported similar responses when cows 
and heifers were given the ·sequence of two PMSG injections plus HCG on 
the day of estrus in the cows or HCG three days after the last PMSG injec-
tion in the heifers. Turpian et al. (1971) and Johnson et al. (1975) re-
ported similar findings when over 50% of the .animals conceiving to the 
first post-PMSG estrus gave birth to twins, triplets or quadruplets. It 
is encouraging that generally less than 20% of all animals treated showed 
more than four ovulations, since uncontrolled ovulations has been one of 
the major difficulties arising from multiple birth studies. 
Hammond (1949), Brock and Rowson (1952) and Scanlon et al. (1968) 
have reported that a more desirable ·and restricted level of superovula-
tion can be obtained when the interval between the last PMSG or FSH injec-
tions and subsequent estrus is relatively short. Similarly Johnson et al. 
(1975) indicated that the majority of multiple births resulting from PMSG 
injection occurred in cows that were ·in estrus two, three, or four days 
after estrus, while Gordon et al. (1962) and Turman et al. (1971) sug-
gested an interval of at least three days as being most desirable. In 
the present study, the within age within treatment correlations between 
interval .after ;FMSG to estrus and number of corpora lutea were nonsigni-
ficant (P ) .05) and ranged from .41 to .32 suggesting that the 
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relationship between these two variables may be minimal. However, since 
cows receiving two injections showed a very low superovulatory response 
while ·also having a mean treatment to estrus interval of 6.9 + .5 days, 
there is the possibility that there is a real relationship between length 
of the interval from PMSG to estrus and superovulatory response. 
Endocrine -Response 
Limited data are available concerning the endocrine response of the 
bovine female following the injection of superovulatory levels of PMSG. 
Such information could yeild useful clues to controlling the many vari-
ables associated with the artificial induction of superovulation in cows. 
This study was primarily aimed at investigating this response, and sub-
sequent sections will deal with the influence of PMSG on plasma proges-
terone, estradiol and LH in both the cow and heifer. 
Progesterone 
Plasma progesterone was determined by radioimmunoassay of jugular 
blood collected at regular intervals during the estrous cycle in which 
PMSG was administered as described previously. Progesterone in cows 
treated with PMSG and plotted by days after estrus (day 0 = estrus) is 
presented in Table IX and Figure 4. Until day 17, the cows given a 
single injection of PMSG were coqsidered as controls to the cows given 
two injections, and exhibited a near normal progesterone curve ·as evi-
denced by peak values of 8. 7 ± .5 ng/ml on day 15. Similar results have 
been reported by many workers including Plotka et al. (1967), Stabenfeldt 
et al. (1969), Sprague ·et al. (1971), Kazama and Hansel (1970), Wettemann 
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single injection of PMSG on day 17 (Trt 17) had similar progesterone to 
those receiving two (Trt 5, 17) injections (3.8 + .3 vs 4.1 ± .3 ng/ml, 
respectively; P )' .25). By 48 hours after Trt 5, 17 received the initial 
day 5 injection, significantly (P ( .025) greater progesterone concen-
trations were detected in their peripheral circulation than in those cows 
on Trt 17 (12.5 ± .8 vs 7.6 ± .6 ng/ ml, respectively). Progesterone 
continued to increase to a peak value of 14.9 ± 2.0 ng/ml on day 17 in 
Trt 5, 17 at which time the concentration for Trt 17 was 7.9 ± .6 ng/ml 
(P < .005). Several explanations could be post4lated concerning this 
progesterone increase after PMSG injection early in the estrous cycle. 
Hoffman et al. (1974) have suggested that LR is luteotrophic in the cow. 
Perhaps the PMSG used in this trial served a similar function on the 
developing corpus luteum from the previous ovulation. Another possibility 
could be that PMSG may cause an endogenous LR release which subsequently 
has a luteotrophic effect. Results reported earlier in this thesis noted 
a number of luteinized follicles after PMSG which was also observed by 
Laster et al. (1971) and Hendricks et al. (1973). The possiblity would, 
therefore, exist that other ovarian tissue stimulated by PMSG might have 
added to the progesterone pool. 
Regardless of the source, progesterone remained elevated for several 
days after the peak in Trt 5, 17 and did not reach a low level in all 
animals until day 25 (1.6 + .6 ng/ml). After the PMSG injection on day 
17, animals on Trt 17 were not stimulated to produce massive amounts of 
progesterone; however, plasma progesterone did not decrease to low 
quantities as rapidly as might be expected in a typical nontreated cow. 
Plasma progesterone in only the cows showing estrus after PMSG is 
treated in Figure 5 and Table X and is plotted by days after the estrus 
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from which treatments were initiated and by days prior to the subsequent 
estrus. The values up to and including day 17 are similar to those re-
ported for all cows (Figure 4). It should be noted, however, that the 
significant increase observed in Trt 5, 17 after the day 5 injection was 
evident one day earlier in the cows showing estrus than in all cows com-
bined. Cows in Trt 5, 17 had elevated progesterone compared to Trt 17 
from one day after the initial treatment until four days prior to the 
next estrus. By day -3 both groups had similar concentrations and con-
tinued to decrease to basal levels on the day of estrus (0. 8 ± .1 vs 1.4 
+ .5 ng/ml for Trt 17 and Trt 5, 17, respectively; P ~ .10). 
Figure 6 and Table XI illustrate plasma progesterone in heifers after 
treatment with PMSG. The results depicted are similar to those seen in 
the cows. The two treatment groups had similar values to day 5; after 
which, a highly significant (P -<_.005) increase to 19.9 ng/ml on day 13 
was seen in the heifers given two injections. After the second injection, 
animals on Trt 5, 17 showed another slight increase on day 18 (18.3 ± 
1.6 ng/ml); but this could have been due to sampling time. Progesterone 
in the single treatment groups increased normally to 10.0 ± .9 ng/ml on 
day 15; but rather than fall to basal levels, it reamined at 10.0 ng/ml 
and then increased to 14.5 ± 3.2 ng/ml four days after treatment. These 
data contradict that reported for cows in that the older animals on Trt 
17 did not show a progesterone increase after the day 17 treatment. 
Spillman et al. (1973) reported that there was no precise time after 
superovulation at which luteal regression occurs in calves. Perhaps 
luteal regression had not occurred in the heifers on day 17; and the PMSG 
was, therefore, able to exert some type of luteotrophic effect; while 
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Progesterone in heifers showing estrus after PMSG is plotted in 
Figure 7 and Table XII. The vast differences in concentrations were also 
evident as early as one day after treatment in those animals that sub-
sequently cycled (4.3 ± .7 vs 6.7 ± .8 ng/ml for Trt 17 and Trt 5, 17, 
respectively; P < .10). These differences remained apparent until day 
-5; after which, both groups decreased to about 1.0 ng/ml by the day of 
estrus. 
Spilman et al. (1973) also reported that luteal and plasma 
progesterone in superovulated mature heifers was maintained approximately 
two to three days longer than in normal cycling heifers. Similarly, 
Hendricks et al. (1973) reported that progesterone remained high for a 
longer period of time in heifers treated with 3200 I.U. PMSG on day 16 
than in those treated with 0 or 1600 I. U. PMSG. Guthrie et al. (1974) 
observed that progesterone in mature gilts treated with PMSG was higher 
four and three days prior to estrus than in untreated animals. These 
suggestions lead to speculation concerning the role of elevated proges-
terone in estrous cycle length. Considering only the cows that exhibited 
estrus after PMSG, the within age within treatment correlations for in-
terval from the last PMSG to estrus and peak progesterone concentration 
were . 76 (P ( .01, n = 12) and .36 (P ) .05, n = 10) for Trt 17 and Trt 
5, 17, respectively. Similar correlations for the heifer groups were 
.97 (P < .01, n = 7) and .83 (P < .01, n = 12) for Trt 17 and Trt 5, 17, 
respectively, suggesting that heifers with a longer than average interval 
from PMSG to estrus tend to have a higher than average peak progesterone. 
Although numbers are inadequate to develop substantial cause-effect re-
lationships, further studies in this area could develop procedures where-
by induced luteolysis after PMSG might prove beneficial in controlling 
1500 IU 2000 IU 
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Figure 7. Plasma Progesterone in Heifers Showing Estrus After 
Treatment With PMSG. 
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problems related to the estrous cycle. Bellows et al. (1974) have 
reported reduced fertility in cows after progestogen treatment. One 
wonders if the increased progesterone seen after PMSG might serve as a 
pharmacologic dose sufficient to not only alter the estrous cycle, but 
also conception rates. 
so 
Spilman et al. (1973) observed a correlation of .76 between peak 
plasma progesterone and number of corpora lutea in superovulated prepu-
beral heifers. Lamond and Gaddy (1972) observed a similar tendency when 
they treated mature heifers with PMSG in two separate trials. These 
workers reported regression coefficients for corpora lutea number and 
plasma progesterone for the two trials of 8.0 + 2.14 ng and ~.2 ± 2.50 
ng. The results obtained in this study closely paralleled these reports 
in that a correlation was observed for all animals treated between number 
of corpora lutea. and pl4sma progesterone of • 75 (P ( .01) with a regres-
sion coefficient of 9.65 ± 1.20 ng/ml (Figure 8). These values were 
determined from a blood sample taken 12 days after estrus following the 
final PMSG injection. In addition, Spilman et al. (1973) reported no 
detectable progesterone in blood samples from a calf that failed to 
ovulate suggesting that PMSG does not induce progesterone production in 
the absence of luteal tissue. Our data were in agreement with this ob-
servation in that progesterone in animals failing to ovulate was generally 
less than one ng 12 days after estrus. These data also indicated no 
apparent relationship between peak progesterone after the final PMSG 
treatment but prior to estrus and subsequent ovulation rate. 
200 
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Plasma estradiol was quantified from all blood samples by 
radioimmunoassay as described earlier. Figures 9 and 10 and Tables XIII 
and XIV depict plasma estradiol in cows and heifers, respectively, after 
treatment with PMSG. Wettemann et al. (1972) reported that estradiol 
remains at low levels until approximately day -3 when a slight increase 
was noted followed by a continual rise to 9.7 pg/ml 0.5 days before 
estrus. Echternkamp and Hansel (1973) reported similar findings. The 
data obtained in this study for Trt 17 cows and heifers support these 
findings in that estradiol generally remained below 5 pg/ml from day 1 
through day 17. Anii:,nals receiving a PMSG injection on day 5, however, 
showed dramatic increases in estradiol by two days after treatment in 
the cow (P < .005) and one day after treatment (P ~ .025) in the heifer 
groups. On day 7, estradiol in cows on Trt 5, 17 was 5.4 ± 1.2 pg/ml 
compared to 2.4 ± .5 pg/ml in cows on Trt 17 (P ( .025). Similar results 
were evident on day 7 in the heifer groups except the magnitude of dif-
ference was much greater (15.1 ± 1.7 vs 4.1 ± 4 pg/ml for Trt 5, 17 and 
Trt 17, respectively; P < .005). The assumption was made that this es-
tradiol increase resulted from follicular growth stimulated by PMSG 
although this was not verified since laparotomies were not performed 
early in the cycle. No animals were detected in estrus after day 5 PMSG 
treatment suggesting, that even though estrogen was increased, the concur-
rent increase in progesterone was still the dominant endocrine factor 
regulating the estrous cycle. 
Estradiol increases were also evident in each treatment group after 
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these data, however, since the normal pre-estrus surge of estradiol could 
be confounded with an estradiol rise resulting from PMSG. Estradiol 
values for cows on day 17 were 2.8 ± .4 in Trt 17 compared to 2.8 ± .8 in 
Trt 5, 17 (P /'.25). By two days after the day 17 treatment, cows on 
Trt 17 had significantly (P <. .025) more estradiol than did those on Trt 
5, 17 (7.2 ± .9 vs 4.2 ± .5 pg/ml, respectively). Similarly, in the 
heifer groups animals on Trt 17 had almost twice as much estradiol as did 
those on Trt 5, 17 on day 19 (17.2 ± 3.2 vs 8.3 ± 2.3 pg/ml, respectively; 
P < . 05). These .differences remained apparent until approximately day -5 
for cows and day -2 for heifers (Figures 11 and 12 and Table XV and XVI) 
at which time no significant di~ferences in estradiol concentrations 
between treatment groups were apparent. On the day of estrus, all treat-
ment groups showed 10-15 pg/ml estradiol. These data indicate that folli-
cular growth in both . cows and heifers can be stimulated by PMSG given 
either early or late in the estrous cycle. This study was not designed 
to permit determining whether the follicles stimulated by the day 5 
injection were the same as those that were subsequently ovulated as sug-
gested by Schilling and Holm (1963). Laster et al. (1971) indicated that 
these may be two different sets of follicles. Similar estrogen increases 
after PMSG late in the cycle were reported for cattle (Hendricks et al., 
1973) and swine (Guthrie et al., 1974). 
Hendricks et al. (1973) reported that plasma estrogen was not 
correlated with follicle number. The data from this study support this 
suggestion since no relationship was apparent between peak estradiol 
after PMSG on day 5 or 17 and corpora lutea number. Some evidence was 
observed in cows on Trt 17, however, concerning a slight relationship 
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follicles greater than 10 mm in diameter present at laparotomy (r = .58; 
n = 16; P < .05). A similar relationship in heifers on Trt 17 only 
approached significance. Similar correlations for peak estradiol after 
the day 5 injection in all animals on Trt 5, 17 were low and nonsignifi-
cant suggesting that follicular growth stimulated early in the cycle may 
not be related to the growth of follicles that ovulated. This supposi-
tion is clouded, however, by the fact that the follicles.observed at 
laparotomy 12 days after estrus may not have been the same as those stim-
ulated during the previous cycle with PMSG. 
Several workers cited earlier have suggested that animals may 
develop a refractory condition to repeated injections of PMSG. This 
study yielded inconclusive evidence concerning this question. All cows 
had been treated in previous years with PMSG. The superovulatory re-
sponse of cows on Trt 17 was low but acceptable; while the response of 
cows on Trt 5, 17 was low and unacceptable with 80% of these animals hav-
ing no or one egg ovulations. Similarly, an increase in plasma estradiol 
after PMSG was evident but not nearly the magnitude of that seen in the 
heifers. In addition, heifers on Trt 5, 17 did not show as great an in-
crease in estradiol after the second injection as that seen after the 
first injection; but the superovulatory response of Trt S, 17 heifers W$ 
at least equal to that seen in Trt 17 heifers. These observations would, 
therefore, possibly suggest that repeated injections of PMSG over several 
breeding :se·asons may lead to a refractory state; but the full e·ffect of 
this condition may require at least two injections in those animals pre-
viously immunized. These data would not, however, support the contention 
that two injections during the same estrous cycle of an animal produces 
refractoriness if that animal had not been treated previously. Studies 
59 
in which animals are laparotomized and follicles observed after a series 
of injections might yeild useful information on this subject. 
Luteinizing Hormone 
Plasma LH was determined from the once-daily bleedings as described 
earlier. Swanson and Hafs (1971) demonstrated that Lli began a gradual 
but nonsignificant rise five days before estrus which was followed by a 
highly significant peak three hours before estrus. This peak was followed 
by a rapid decline to basal levels four to six hours later in normal cycl-
ing animals. Spilman et al. (1973) demonstrated that plasma LH rose 
sharply on the day after PMSG injection and declined thereafter in pre-
puberal and mature heifers. Estrogen secretion may regulate LH release 
in cattle (Wetteman et al., 1972). Spilman et al. ( 1972) reasoned, there-
fore, that the LH incre'ase seen after PMSG resulted from endogenous estro-
gen secretion from PMSG-stimulated follicles. Hendricks et al. (1973) 
reported an LH rise earlier in PMSG treated heifers than in controls 
prior to estrus. These previous results would indicate that plasma LH 
may be ,affected by PMSG treatment. 
LH data from the present study were variable due most likely to the 
fact that samples were collected on a daily basis. Figures 13 and 14 and 
Table XVII and XVIII show plasma LH in cows and heifers treated with 
PMSG. LH was not influenced by treatment within age groups and values 
throughout the estrous cycle remained approximately 1. 0 ng/ml. In addi-
tion, no elevations in LH above two ng/ml were evident in any of the 
treatment groups between days 5 and 7 of the estrous cycle. However, 55% 
and 67% of the heifers on Trt 17 and Trt 5, 17, respectively, had at 
least one sample with greater than two ng/ml LH between day 17 and estrus. 
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Fifty-six percent of the cows on Trt 17 had similar elevations; while 
only 13% of the cows on Trt 5, 17 showed increased LH ne·ar the expected 
time of estrus. This failure of the cows on Trt 5, 17 to show elevated 
LH may at least partially explain the fart that 20% of these animals 
failed to ovulate 'after PMSG treatment. 
No significant relationship was detected between plasma estrogen and 
plasma LH or between plasma LH and ovulation rate. Similarly, Hendricks 
et al. (1973) failed to detect a relationship between plasma LH and re-
productive criteria after PMSG treatment. 
CHAPTER V 
SUMMARY 
This study was designed to examine the endocrine and reproductive 
response of the bovine female to PMSG. Treatments were employed that 
would allow these responses to be compared in animals treated only during 
the late luteal phase of the estrous cycle to the response when animals 
were treated both during the early and the late luteal phases of the 
cycle. Fifty-four straightbred Angus females including 31 multiparous 
lactating cows and 23 two year-old heifers were used in this trial. Each 
age group of animals were randomly allotted to one of two treatment 
groups after each animal had exhibited at least one normal estrous cycle. 
Sixteen cows and 11 heifers received a single subcutaneous injection 
of 2000 I.U. PMSG on day 17 (day 0 =estrous) of their estrous cycle; 
while 15 cows and 12 heifers received 1500 I.U. PMSG on day 5 followed 
by 2000 I.U. PMSG on day 17. All animals were bled by jugular venipunc-
ture at regular intervals during the estrous cycle in which PMSG treat-
ments were imposed, and plasma progesteroqe, estradiol and luteinizing 
hormone were subsequently determined by radioimmunoassay. At the first 
estrus after the last PMSG injection, the animals were bred by natural 
service to Angus bulls. A high lumbar laparotomy was performed on each 
animal seven to 11 days after breeding, and a final blood sample was 
collected 12 days after breeding. 
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Seventy-five percent of the cows and 63.6% of the heifers on Trt 17 
exhibited estrus after PMSG; while 66.7 and 100% of the cows and heifers, 
respectively, on Trt 5, 17 showed estrus after PMSG. Estrous cycle length 
was significantly (P.( .05) increased in cows by giving PMSG both during 
the early and late luteal phases of the cycle compared to injection only 
during the late luteal phase (23.9 ± .5 vs 21.9 ± .7 days, respectively). 
Similar results were obtained in the heifer groups (23.6 ± .5 vs 21.6 ± 
1.1 days for Trt 5, 17 and Trt 17, respectively; P <: .10). Conception 
rates at the first estrus after PMSG as determined by rectal palpation 
were 62.5% and 45.4% for cows and heifers, respectively, on Trt 17 and 
60% and 75% for cows and heifers, respectively, on Trt 5, 17. Similar 
pregnancy rates determined by examining breeding dates after parturition 
were 56.2% and 18.2% for Trt 17 and 40% and 33.3% for Trt 5, 17. 
Cows treated with a single injection of PMSG had a higher ovulation 
rate than those treated on days 5 and 17 (2.2 ± .4 vs 1.3 ± .3, respec-
tively; P < .10). Although the difference in ovulation rate in heifers 
was not significant (P > .25), animals treated on days 5 and 17 tended to 
have more ovulations than those treated only on day 17 (4.3 + 1.1 vs 3.1 
± 1.2; respectively). Several animals in each treatment group failed to 
ovulate with the exception of heifers given two injections of PMSG. Simi-
larly, no treatment differences were evident for animals showing a single 
ovulation. Fifty percent of the cows and 36% of the heifers on Trt 17 
had two, three or four ovulations; while 13% of the cows and 50% of the 
heifers on Trt 5, 17 had two to four egg ovulations. Approximately six 
percent of the cows and 20% of the heifers had more than four ovulations. 
No significant differences in total ovarian diameter or number of follicles 
less than 10 mm in diameter were detected in any of the treatment groups; 
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while cows given one injection of PMSG tended to have more follicles 
greater than 10 mm in diameter than those receiving two injections (2.8 
+ .5 vs 1.5 ± .4, respectively; P <: .10). 
Cows on Trt 17 showed a near normal progesterone curve with a peak 
of 8.7 ± .5 ng/ml on day 15. A slight but nonsignificant increase was 
seen in these animals on day 20, after which the progesterone values de-
creased to basal levels. Progesterone did not seem to be adversely 
affected in cows when PMSG was given late in the luteal phase of the es-
trous cycle. Cows treated with two injections of PMSG had similar values 
to day 5 after which a sharp increase was evident to a peak of 14.9 ± 
2.0 ng/ml on day 17 (P < .005). A further progesterone increase was not 
apparent in these animals after the day 17 injection although the initial 
progesterone surge was maintained for a longer period of time than would 
be expected in a normal cycling animal. 
A similar response to early luteal PMSG was noted in heifers. By 
four days after treatment, heifers on Trt 5, 17 had a progesterone value 
of 14.8 + 1.2 ng/ml compared to 7.8 ± .7 ng/ml at the same time for Trt 
17. These high values were maintained in Trt 5, 17 until approximately 
three days after the second injection after which they fell to basal 
levels. Progesterone in the single treated heifers increased normally to 
10.5 ± 1.1 ng/ml on day 13 and remained at that level until day 20 then 
increased to 14.5 ± 3.2 ng/ml four days after treatment. This increase 
was followed by a rapid decline to basal levels at the time of estrus. 
These data indicate that a progesterone response can be elicited in heifers 
by giving PMSG either early or late in the luteal phase of the estrous 
cycle. 
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Some degree of relationship was noted between plasma progesterone 
after day 17 and the interval from PMSG to estrus. In addition, plasma 
progesterone 12 days post breeding was significantly related to number of 
corpora lutea (r = .75, P < .01). No apparent realtionship between peak 
progesterone after PMSG and ovulation .rate was detected. 
Plasma estradiol in cows and heifers that were not treated during 
the early luteal phase of the estrous cycle generally remained below 5 
pg/ml from day 1 through day 17. Animals receiving PMSG on day 5, how-
ever, showed dramatic increases in estradiol by 2 days after treatment in 
the cow (P < .005) and one day after treatment (P ~ .025) in the heifer 
groups suggesting increased follicular growth after PMSG. None of the 
animals that were treated on day 5 exhibited estrus as a result of in-
creased estradiol which was due most probably to the concurrent rise in 
progesterone at the same time. 
Estradiol increases were also evident after all animals were treated 
on day 17. By two days after the day 17 treatment, cows on Trt 17 had 
significantly more estradiol (P <.. 025) than did thos·e on Trt 5, 17 (7. 2 
± .9 vs 4.2 ± .5 pg/ml, respectively). Heifers on Trt 17 had almost 
twice as much estradiol on day 19 as did those on Trt 5, 17 (17.2 ± 3.2 
vs 8.3 ± 2.3 pg/ml, respectively). These differences remained apparent 
until day -5 for cows and day -2 for heifers at which time no treatment 
differences were detected. These data indicate that follicular growth 
can be stimulated in both cows and heifers by PMSG given during either 
the early or late luteal phases of the estrus cycle. Considering that 
all the cows and none of the heifers had been treated in previous years 
with PMSG, one might speculate by examining the ovulation and estradiol 
data that animals treated over a several year period may develop some 
degree of refractoriness to the second of two PMSG injections given in 
the same cycle. 
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No relationship was apparent between peak estradiol concentration 
after PMSG on day 5 or 17 and corpora lutea number. A slight relation-
ship between animals treated on day 17 was evident between peak estradiol 
and number of corpora lutea considered in conjunction with follicles 
greater than 10 mm in diameter. No such relationship after the day 5 
injection was seen in the animals on Trt 5, 17. 
Plasma LH concentrations were highly variable throughout the estrous 
cycle in which PMSG injections were imposed and generally remained below 
1.0 ng/ml. No significant differences in plasma LH were detected in any 
of the treatment groups suggesting that PMSG does no influence plasma 
LH values. However, LH concentration seems to be highly variable and 
rapidly metabolized suggesting that once daily bleedings may not be suf-
ficient to detect changes in LH associated with PMSG treatment. 
The data accumulated in this study suggest that PMSG has profound 
effects on both the ovarian and endocrine response of the bovine female. 
Research efforts aimed at controlling the progesterone and estradiol 
concentrations around the time of the post-PMSG estrus may answer some 
of the questions associated with inducing multiple pregnancies in cattle. 
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STOCK BUFFER SOLUTIONS USED IN IMMUNOASSAY 
PROCEDURES 
A. Monobasic Sodium Phosphate Buffer (O.S M) 
Weigh 69.0 g NaH2P04 • H20 (monobasic) and dilute to 1,000 ml with 
glass distilled water. Store at 5 C. 
B. Dibasic Sodium Phosphate Buffer (O.S M) 
Weigh 71.0 g andydrous or 134 g heptahydrate Na2HP04 (dibasic) and 
dilute to 1,000 ml with glass distilled water. Store at 5 C. 
C. Stock Phosphate Buffered Saline (0.05 M) 
1. 120 ml of Monobasic Buffer (A) 
2. 240 ml of Dibasic Buffer (B) 
3. 143 g sodium chloride, NaCL 
4. 1.75 g Thimerosol (Merthiolate) 
5. Add glass distilled water to a final volume of 3500 ml 
6. Check pH 7.0; adjust if necessary using sodium hydroxide or 
phosphoric acid and store at 5 C 
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TABLE VII 
WORKING BUFFER SOLUTIONS USED IN IMMUNOASSAY 
PROCEDURES 
A. Phosphate Buffered Saline Working Solution (PBS) 
Dilute one part l>BS Stock with four parts glass distilled water. 
B. Phosphate Buffered Saline Plus 0.1% Gelation (PBS+ Gel) 
76 
Weigh one gram Knox Gelatin and dilute to 1,000 ml with PBS Working 
Solution. 
C. Phosphate Buf~_ered Saline Plus Ethylenedinitrilotetra-acetic acid-
Disodium Salt (PBS + EDTA) (0.05 M) 
1. Weigh 18.61 g disodium EDTA 
2. Add about 800 ml PBS, warm and stir until dissolved 
3. Adjust pH to 7.0 by adding 5 N NaOH while stirring 
4. Adjust volume to 1,000 ml with PBS and store at 5 C 
TABLE VIII 
PREPARATION OF LIQUID SCINTILLATION FLUIDS 
A. Steroid Counting Fluid 
Toluene (Scintillation Grade) 
PPO 
POPOP 
Mix until dissolved 
B. Protein Binding Counting Fluid 
Toluene (Scintillation Grade) 
PPO 





21. 7 g 
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TABLE IX 
PLASMA PROGESTERONE IN CCMS TREATED WITH PMSG 
Day of Trt 17 Trt 5, 17 Probability 
Cycle (ng/ml) (ng/ml) (Type I) 
1 0.7 + .la 0.6 + .1 > .25 
3 1.8 + .2 1.9 + .3 > .25 
5 3.8 ± .3 4.1 ± .3 > .25 
6 5.1 + .4 6.1 + .s > .10 
7 6.5 ± .3 8. 7 ± . 7 < .025 
9 7.6 + .6 12.5 + .8 < .oos 
11 7.6 + .5 13.6 ± 1.1 < .005 
13 8.1 + .7 13.5 + 1. 0 < . 005 
15 8. 7 + .s 14. 3 + 1. 7 < .005 
17 7.9 + . 6 14.9 + 2.0 < .005 
18 7.5+1.0 14. 3 + 1. 9 ( .005 
19 5.6 + 1.1 13.1 + 2.4 <.OS 
20 6.1 + 1.6 10.9 + 1.9 .( .10 
21 3.6+1.0 6.9+1.6 > .10 
22 2.4 + 1.3 4. 7 + 1.3 > .25 
23 2.3 + 1.1 4.6 + 1.7 > .25 
24 2.8 + 1.8 2.0 + .8 > .25 
25 3.2 + 2.1 1.6±.6 > .25 




















8 Mean + S. 
.TABLE X 
PLASMA PROGESTERONE IN COWS SHCMING ESTRUS AFTER 
TREATMENT WITH PMSG 
Trt 17 Trt 5, 17 
(ng/ml) (ng/ml) 
0.6 + .la 0.6 + .1 
1.8 + .2 2.0 + .4 
4.0 + .3 4.2 + .3 
5.4 + .5 7.0 ± .5 
6.7 + .4 9.4 ± .9 
7.8 + . 7 13.2 + .9 
7. 6 + . 6 14.5 ± 1.2 
7.8 ± .8 14.5 ± 1.0 
8.8 + .6 15.2 ± 2.3 
7.6 + .7 16.0 + 2.1 
8.2 + 1.2 13.5 + 2.6 
8.2 ± 1.2 14.4 ± 2.1 
8.2 + 1.4 9.6+1.0 
6.3 + 1.0 7.3 + 2.0 
2.4 ± .5 4.1 + 1.4 
1.0 + .1 2.2 + 1.1 
























PLASMA PROGESTERONE IN HEIFERS TREATED WITH PMSG 
Day of Trt 17 Trt S, 17 Probability 
Cycle (ng/ml) (ng/ml) (Type I) 
1 0.9 + .la 0.9 + .2 > .2S 
3 l.S ± .2 2.0.±.4 > .2S 
s 3.S + .4 4.1 + .s > .2S 
6 4.3 + .s 6.7 ± .8 <..OS 
7 6. 6 + .7 9.6 + 1.1 < .OS 
9 7.8 ± .7 14. 8 + 1.2 < .oos 
11 9.8 ± .9 19.4 ± 1.2 < .oos 
13 10. s + 1.1 19.9 ± 1.0 < .oos 
--
lS 10~0"± .9 19.2 + 1.8 < .oos 
17 9.3 ± 1.2 16.1+1.3 < .oos 
18 9.9 ± 1.9 18.3 ± 1.6 <. .oos 
19 10.0 + 2.1 14.8 + 1. 8 > .10 
20 9.8 ± 2.0 11.4 ± 2.2 > .2S 
21 14.S + 3.2 7.4 + 2.2 > .10 
22 10.0 + 2.4 4.2 1.3 ~ .OS 
23 6.6 2.7 2.6 .7 > .10 
24 3.S + 1.4 1.4 + .3 > .10 
2S 2.6 ± .s 1.2 + .2 ~.OS 





















aMean + S. E. 
TABLE XII 
PLASMA PROGESTERONE IN HEIFERS SHCMING ESTRUS 
AFTER TREATMENT WITH PMSG 
Trt 17 Trt 5, 17 
(ng/ml) (ng/~1) 
1.0 +.la 0.9 ± .2 
1.5 .3 2.0 + .4 
3.3 ± .5 4.1 + .5 
4. 3 + • 7 6.7 ± .8 
6.3 1.0 9.6 + 1.1 
7.1 ± 1.0 14. 8 ± 1.2 
8.7 + 1.1 19.4 + 1.2 
9.7 1. 6 19.9 + 1.0 
9.0 + 1.3 19.2 ± 1.8 
8.1 ± 1.7 16.1+1.3 
13.2 + 1.8 17.4 + 2.0 
9.9 + 1.6 15. 3 + 1. 7 
15.8 + 2.3 13.0 + 1.8 
8.9 + 1.9 8.3 + 1.0 
4.0 ± 1.1 4.6+1.0 
1.4 + .2 1. 7 ± .2 























PLASMA ESTRADIOL IN COWS TREATED WITH PMSG 
Day of Trt 17 Trt 5, 17 Probability 
Cycle (pg/ml) (pg/ml) (Type I) 
1 2.0 ± .3a 1.6 ± .2 > .10 
3 2.1 + .2 2.2 ± .4 > .25 
5 2.7 + .4 2.1 ± .3 >.10 
6 2.1 + .4 4.9 + .6 < .005 
7 2.4 ± .5 5.4 ± 1.2 < .025 
9 2.7 ± .4 10.6+1.6 ~ .005 
11 2.0 ± .2 9.9 ± 2.6 < .005 
13 2.4 ± .3 4.8 ± 1.4 .,., .10 
15 2.2 ± .2 3.4 + 1.0 >.10 
17 2.8 + .4 2.8 + .8 > .25 
18 5.0 + .5 4.0 + 1.3 > .25 
19 7.2 + .9 4.2 + .5 c:::.. 025 
20 8.2 + 1.0 4. 6 + .6 < .025 
21 11.0 ± 2. 7 5.7 ± 1.1 < .10 
22 8.9+1.3 7.4 ± 1.7 > .25 
23 15.8 ± 4.2 9.6 + 2.1 > .10 
24 11.9+7.7 12.7 ± 3.4 ') .25 
25 17.8 ± 14.8 14.8 + 4.7 > .25 
8 Mean ± S. E. 
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TABLE XIV 
PLASMA ESTRADIOL IN HEIFERS TREATED WITH PMSG 
Day of Trt 17 Trt 5, 17 Probability 
Cycle (pg/ml) (pg/ml) (Type I) 
1 3.6 ± .5a 2.9 + .4 >.25 
3 3.2 + .4 3.8 + .3 = .25 
5 5.0 + .4 5.6 ± .7 >.25 
6 4.6 ± .5 10.0 ± 1.8 <.025 
7 4.1 + .4 15 .1 ± 1. 7 < .005 
9 3.0 + .4 30.0 ± 4.9 < .005 
11 5.4 + .8 57.6 + 14.4 < .005 
13 3.5 ± .7 38.8 + 13.7 < .05 
15 3.9 + .9 13.3 ± 7.3 = .25 
17 6.5 ± 1.8 6.7 + 2.0 > .25 
18 9.6±1.4 8.3 ± 2.8 > .25 
19 17.2 ± 3.2 8.3 + 2.3 < .05 
20 27.0 + 7.7 9.8 ± 2.2 < .05 
21 51.5 ± 18.9 14.3 + 3.7 .( .05 
22 53.l ± 18.9 22.5 ± 6.7 = .10 
23 46.1+18.8 19.0 + 8.6 > .10 
24 42.9 ± 17.5 11.2 + 3.8 > .10 
25 35.3 + 32.2 10.1 + 3.4 > .25 




















a'Mean ± s. E. 
TABLE XV 
PLASMA ESTRADIOL IN COWS SHOWING ESTRUS AFTER 
TREATMENT WITH PMSG 
Trt 17 Trt 5, 17 
(pg/ml) (pg/ml) 
1. 9 ± .3a 1.5 ± .2 
2.0 + .2 2.5 + .4 
2.3 ± .4 2.3 ± .4 
1. 9 + .4 5.7 + .6 
2.5 + .7 6.7±1.6 
2.4 ± .5 9.6 + 1.8 
1.8 + .2 7.9 ± 2.0 
2.4 + .3 5.1 ± 2.0 
1.9 ± .2 4.1+1.4 
2.7 ± .6 3.3 + 1.1 
9.6+1.5 3.7 + .5 
5.8 + .9 4.6+1.4 
5.7±1.7 6.5 + 2.3 
4.8 + 1.0 6.7 + 1.9 
6.0±1.l 9.9 + 2.9 
8.9 ± 1.3 12.9 ± 4.0 










































PLASMA ESTRADIOL IN HEIFERS SHOWING ESTRUS AFTER 
TREATMENT WITH PMSG 
Trt 17 Trt 5, 17 
(pg/ml) (pg/ml) · 
3.3 + .Sa 2.9 ± .4 
3.1 + .5 3.8 + .3 
5.1 + .3 5.6 ± • 7 
4.8 ± .8 10.0 + 1.8 
4.3 ± .4 15 .1 ± 1. 7 
3.3 + .6 30.0 + 4.9 
6.7 + 1.1 57.6 ± 14.4 
4.1 ± • 9 38.8 + 13.7 
4.2 + 1.4 13.3 ± 7.3 
8.1 ± 2.7 6.7 + 2.0 
22.0 + 9.9 5.0 ± .7 
28.6 ± 15.2 4.2 + .4 
54.2 ± 36.3 8.9 + 3.0 
56.5 + 36.0 12.1 ± 2.5 
33.2 ± 20.1 14.1 ± 3.5 
30.6 + 10.9 18.8 + s.o 























PLASMA LH IN COWS TREATED WITH PMSGa 
Day of Trt 17 
Cycle (ng/ml) 
1 0.5 + .1 b 
3 o. 7 + .1 
5 0.5 + .1 
6 0.4 + .1 
7 0.4 + • 1 
9 0.4 ± .1 
11 0.3 ± .1 
13 0.4 ± .1 
15 0.3 + .1 
17 0.3 ± .1 
18 o. 7 + .2 
19 1.2 + .6 
20 0.8 + .2 
21 1.1 ± .2 
22 1.6 + 1.0 
23 0.9 + .4 
24 1.2 ± .7 
25 1.3 ± .5 
aNo Significant Treatment Differences 
bMean ± s. E. 
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Trt 5, 17 
(ng/ml) 
o. 7 + .1 
0.8 + .1 
0.5 ± • 1 
0.8 + .2 
o. 7 + .1 
0.7 ± .1 
0.5 + .1 
0.4 + .1 
0.3 ± .1 
0.4 + .1 
0.5 + .1 
0.6 ± .1 
0.8 + .2 
0.7 + .2 
0.4 + .1 
o. 6 + .2 
0.8 ± .2 
0.9 + .4 
TABLE XVIII 
PLASMA LH IN HEIFERS TREATED WITH PMSGa 
Day of Trt 17 
Cycle (ng/ml) 
1 1.0 + .3 b 
3 1.1 + .2 
5 0.8 + .3 
6 1.2 + .4 
7 0.8 + .2 
9 0.5 ± .2 
11 1.2 + .6 
13 0.8 ± . 2 
15 0.8 ± .2 
17 1.0 ± .2 
18 1.3 + .2 
19 2.1 + .7 .-
20 1.4 + .5 
21 1.2 + .4 
22 2.4 ± 1.0 
23 1.2 + .3 
24 1.3 + .3 
25 1.6 + .4 
aNo Significant Treatment Differences 
bMean ± S. E. 
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Trt 5, 17 
(ng/ml) 
0.8 + .2 
0.7 + .1 
0.6 ± .2 
1.2 ± .1 
0.9 + .2 
0.9 + .1 
1.3 + .1 
0.8 + .1 
0.8 ± .1 
0.9 ± .1 
1.5 + .2 
1.5 + .1 
1. 6 + .2 
1.6 + .2 
1. 7 + .2 
1. 7 ± .2 
1.8 + .2 
2.5 ± 1.3 
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